Powerhouse Podcast

Introducing a special episode of the Powerhouse Podcast: Making Sense of Mito - FBXL4-Associated Mitochondrial Disease. This special edition episode spotlights researchers and the years of scientific work to understand FBXL4 alongside the stories and perspectives of parents of children impacted by FBXL4-associated mitochondrial disease. Helping to Make Sense of Mito are our co-hosts: two researchers from Washington University in St. Louis, Keri-Lyn Kozul, PhD and Hannah Pletcher, and mito mom/podcaster/foundation co-founder, Susan Geoghegan. This special episode bridges the gap to tell the story of FBXL4, bringing together the "team" working toward treatments, including the patient families and the scientists FEATURED GUESTS · Janice Belcher, mom to Juliet · David Alsina, PhD, Laarson Lab at Karolinska Institute, Sweden: https://ki.se/en/people/david-alsina o The Laarson Lab: https://molmet.ki.se/nils-goran-larsson · Mike and Susan Geoghegan, parents to Lorelei and Benji · Julia Pagan, PhD, Pagan Lab at University of Queensland, Australia: https://biomedical-sciences.uq.edu.au... o The Pagan Lab: https://biomedical-sciences.uq.edu.au... · Natalie Niemi, PhD, Niemi Lab at Washington University, St. Louis, MO, US: https://biochem.wustl.edu/faculty/niemi o The Niemi Lab: https://www.niemilab.com · Kevin and Courtney Kline, parents to Emery Special thanks to the families who contributed photos of their children. REFERENCED IN THIS EPISODE Apricity Hope Project: https://apricityhope.org When Autumn Comes: https://apricityhope.org/autumn/ Live Like Lorelei: Amazon link to purchase UMDF's Mitochondrial Medicine Conference: https://umdfconference.org/

We'd proud to introduce you to Making Sense of Mito - FBXL4-Associated Mitochondrial Disease. In this new episode (dropping soon), Dr. Keri-Lyn Kozul, PhD and Hannah Pletcher, researchers from Wash U St. Louis, and Susan Geoghegan of Apricity Hope Foundation team up to weave the science and the patient journeys together into the story of FBXL4, an ultra rare mitochondrial disease. Listen in as we tease out how this special episode came to be and the hopes for all it will become to both our research and patient communities. Featured Guests: Keri-Lyn Kozul, PhD and Hannah Pletcher Niemi Lab at Washington University, St. Louis https://www.niemilab.com Susan Geoghegan The Apricity Hope Project https://apricityhope.org/susan-geoghegan/

On this November's Powerhouse Podcast episode, we're proud to feature runners from our 2024 UMDF Team Activate who fundraised and ran in the Bank of America Chicago Marathon. Listen in as Micah, Lisa, and Aaron share with us their training tips, race day peaks and valleys, and their experiences putting their miles toward the mission of UMDF. If you're interested in going the distance toward treatments and cures for mitochondrial disease like these runners, contact us about a spot on our 2025 Team Activate charity team. Email angela.sommer@umdf.org

On this special edition of the Powerhouse Podcast, Miranda Franco, Senior Policy Advisor for Holland & Knight, joins us for a recap of new movements in mito-related legislation and the ways we could use your help in governmental advocacy for the mitochondrial disease patient community. Take action at umdf.org/advocacy.

Join us for the Powerhouse Podcast this month featuring Leslie Kirby, co-founder of Run4Raley, as the Kirby family is heading into their 17th year of their fundraising event in Philo, IL. Leslie shares about the work they've done as a tribute to their daughters, Raley and Aubree, at their local hospital and in fundraising for UMDF to help other families like them. Learn more about Run4Raley and Hope4Aubree at run4raley.org

In this latest episode, join UMDF's Brian Harman and Dr. Philip Yeske in a talk with guests, Todd Lacey from the UMDF Board of Trustees and Dan DiPietro, Co-Founder of Pierrepont Therapeutics. On the advent of The Mito Fund's inaugural investment in Pierrepont's enzyme replacement therapy for patients with MNGIE, they share insight on the potentially game-changing research investment and new strategic partnership.